As of Oct 21
| +0.0016 / +0.25%|
The 5 analysts offering 12-month price forecasts for TearLab Corp have a median target of 2.00, with a high estimate of 3.00 and a low estimate of 0.90. The median estimate represents a +217.46% increase from the last price of 0.63.
The current consensus among 5 polled investment analysts is to Buy stock in TearLab Corp. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.